|Generate QR code
Open Access
Subscription Access
Acute motor axonal neuropathy: features of diagnosis, treatment and rehabilitation
V. B. Voitenkov,
I. G. Samojlova,
E. Yu. Skripchenko,
I. V. Cherkashina,
A. V. Klimkin,
M. A. Irikova,
P. S. Verbenko https://doi.org/10.30629/2658-7947-2024-29-6-20-26
Abstract
Acute axonal motor neuropathy (AMAN) is an axonal variant of Guillain-Barré syndrome, characterized by acute damage of motor fibers of peripheral nerves. In the acute period, therapy involves the use of specific and nonspecific methods. Specific methods include operations of high-volume program plasmapheresis and courses of high-dose intravenous immunotherapy with immunoglobulin class G preparations. Nonspecific methods consist of symptomatic therapy. It is very important to start rehabilitation treatment with a multidisciplinary team of specialists as early as possible in the period of reconvalescence.
About the Authors
V. B. Voitenkov
Pediatric Research and Clinical Center for Infectious Diseases; Academy of postgraduate education under FSBU FSCC of FMBA of Russia
Russian Federation
Russian Federation
St. Petersburg
Moscow
I. G. Samojlova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
St. Petersburg
E. Yu. Skripchenko
Pediatric Research and Clinical Center for Infectious Diseases; St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
St. Petersburg
I. V. Cherkashina
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
St. Petersburg
A. V. Klimkin
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
St. Petersburg
M. A. Irikova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
St. Petersburg
P. S. Verbenko
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
St. Petersburg
References
1. van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023;30(12):3646–3674. https://doi.org/10.1111/ene.16073
2. Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288
3. Collet R., Caballero-Ávila M., Querol L. Clinical and pathophy-siological implications of autoantibodies in autoimmune neuropathies. Rev Neurol (Paris). 2023;179(8):831–843. https://doi.org/10.1016/j.neurol.2023.02.064
4. Censi S., Bisaccia G., Gallina S., Tomassini V., Uncini A. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’. Eur J Neurol. 2024;31(2):e16094. https://doi.org/10.1111/ene.16094
5. Filosto M., Cotti Piccinelli S., Gazzina S., Foresti C., Frigeni B., Servalli M.C., Sessa M., Cosentino G., Marchioni E., Ravaglia S., Briani C., Castellani F., Zara G., Bianchi F., Del Carro U., Fazio R., Filippi M., Magni E., Natalini G., Palmerini F., Perotti A.M., Bellomo A., Osio M., Nascimbene C., Carpo M., Rasera A., Squintani G., Doneddu P.E., Bertasi V., Cotelli M.S., Bertolasi L., Fabrizi G.M., Ferrari S., Ranieri F., Caprioli F., Grappa E., Manganotti P., Bellavita G., Furlanis G., De Maria G., Leggio U., Poli L., Rasulo F., Latronico N., Nobile-Orazio E., Beghi E., Padovani A., Uncini A. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study. Eur J Neurol. 2022;29(11):3358–3367. https://doi.org/10.1111/ene.15497
6. Liu S., Zhang W.W., Jia L., Zhang H.L. Guillain-Barré syndrome: immunopathogenesis and therapeutic targets. Expert Opin Ther Targets. 2024;28(3):131–143. https://doi.org/10.1080/14728222.2024.2330435
7. Rose M.Q., Santos C.D., Rubin D.I., Siegel J.L., Freeman W.D. Guillain-Barré Syndrome After Acute Hepatitis E Infection: A Case Report and Literature Review. Crit Care Nurse. 2021;41(4):47–53. https://doi.org/10.4037/ccn2021129
8. Dalugama C., Shelton J., Ekanayake M., Gawarammana I.B. Dengue fever complicated with Guillain-Barré syndrome: a case report and review of the literature. J Med Case Rep. 2018;12:137. https://doi.org/10.1186/s13256-018-1626-y
9. Lim C.S., Kaisbain N., Lim W.J. A Rare Combination: Dengue Fever Complicated With Guillain-Barre Syndrome. Cureus. 2023;15(6):e40957. https://doi.org/10.7759/cureus.40957
10. Doets A.Y., Verboon C., van den Berg B., Harbo T., Cornblath D.R., Willison H.J., Islam Z., Attarian S., Barroso F.A., Bateman K., Benedetti L., van den Bergh P., Casasnovas C., Cavaletti G., Chavada G., Claeys K.G., Dardiotis E., Davidson A., van Doorn P.A., Feasby T.E., Galassi G., Gorson K.C., Hartung H.P., Hsieh S.T., Hughes R.A.C., Illa I., Islam B., Kusunoki S., Kuwabara S., Lehmann H.C., Miller J.A.L., Mohammad Q.D., Monges S., Nobile Orazio E., Pardo J., Pereon Y., Rinaldi S., Querol L., Reddel S.W., Reisin R.C., Shahrizaila N., Sindrup S.H., Waqar W., Jacobs B.C.; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–2877. https://doi.org/10.1093/brain/awy232
11. Skripchenko N.V., Vilnitz A.A., Egorova E.S., Skripchenko E.Yu., Klimkin A.V., Voytenkov V.B., Konev A.I., Alekseeva L.A. Pediatric neuroinfection emergencies. Russian Pediatric Journal (Rossiiskii pediatricheskii zhurnal). 2022;3(1):287 (Russian). https://www.rospedj.ru/jour/article/view/447/377 (доступ не ограничен).
12. Carpentier V.T., Le Guennec L., Fall S.A.A., Viala K., Demeret S., Weiss N. Syndrome de Guillain-Barré: physiopathologie et aspects diagnostiques [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome]. Rev Med Interne. 2022;43(7):419–428. https://doi.org/10.1016/j.revmed.2021.12.005
13. Bazán-Rodríguez L., Ruiz-Avalos J.A., de Saráchaga A.J., Martinez-Jimenez E., López-Hernández J.C., Vargas-Cañas S. Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton Neurosci. 2023;245:103070. https://doi.org/10.1016/j.autneu.2022.103070
14. Chakraborty T., Kramer C.L., Wijdicks E.F.M., Rabinstein A.A. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocrit Care. 2020;32(1):113–120. https://doi.org/10.1007/s12028-019-00781-w
15. Cheng Y., Liu K., Li C., Zhang W., Wu X., Fang S. Risk Factors for Mechanical Ventilation in Patients with Guillain-Barré Syndrome. Neurocrit Care. 2022;37(1):121–128. https://doi.org/10.1007/s12028-022-01457-8
16. Luijten L.W.G., Doets A.Y., Arends S., Dimachkie M.M., Gorson K.C., Islam B., Kolb N.A., Kusunoki S., Papri N., Waheed W., Walgaard C., Yamagishi Y., Lingsma H., Jacobs B.C. IGOS Consortium. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2022;94(4):300–308. https://doi.org/10.1136/jnnp-2022-329937
17. Galassi G., Mazzoli M., Ariatti A., Bedin R., Marzullo D., Bastia E., Agnoletto V., Gozzi M., Valzania F., Meletti S., Marchioni A. Predictors of respiratory failure in Guillain-Barré syndrome: a 22 year cohort study from a single Italian centre. Eur J Neurol. 2024;31(1):e16090. https://doi.org/10.1111/ene.16090
18. Wachira V.K., Farinasso C.M., Silva R.B., Peixoto H.M., de Oliveira M.R.F. Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review. Glob Epidemiol. 2023;5:100098. https://doi.org/10.1016/j.gloepi.2023.100098
19. Hagen K.M., Ousman S.S. The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci. 2021;12:613628. https://doi.org/10.3389/fnagi.2020.613628
20. Suponeva N.A., Piradov M.A., Nikitin S.S., Timchenko O.L., Gracheva L.A., Bykova L.P., Lapin S.V., Fed’kina Yu.A., Kostyreva M.V., Shabalina A.V., Grishina D.A. Pathogenetic and prognostic role of autoantibodies to peripheral nerve gangliosides in Guillain-Barré syndrome. Annals of Clinical and Experimental Neurology (Annaly klinicheskoi i eksperimental’noi nevrologii). 2013;7(1):4–11 (Russian). https://cyberleninka.ru/article/n/patogeneticheskaya-i-prognosticheskaya-rol-autoantitel-k-gangliozidam-perifericheskih-nervov-pri-sindrome-giyena-barre. (доступ не ограничен).
21. Kozyreva A.A., Bembeeva R.T., Druzhinina E.S., Zavadenko N.N. Guillain-Barre syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2023;123(9):20–32 (Russian). https://doi.org/10.17116/jnevro202312309220
22. Wu X., Shen D., Li T., Zhang B., Li C., Mao M., Zhao J., Liu K., Zhang H.L. Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China. PLoS One. 2016;11(3):e0151611. https://doi.org/10.1371/journal.pone.0151611
23. Shibeshi M.S., Mengesha A.A., Gari K.T. Pediatric Guillain-Barré Syndrome in a Resource Limited Setting: Clinical Features, Diagnostic and Management Challenges, and Hospital Outcome. Pediatric Health Med Ther. 2023;14:107–115. https://doi.org/10.2147/PHMT.S401461
24. Jin M., Liu J., Liu K., Zhao L., Zhao Z., Sun S. Sympathetic skin response (SSR) in pediatric Guillain-Barré syndrome. Front Neurol. 2023;14:1177394. https://doi.org/10.3389/fneur.2023.1177394
25. Al Amrani F., Al-Abdwani R., Al Rashdi F., Al-Ajmi E., Al Futaisi A. Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients. Sultan Qaboos Univ Med J. 2023;23(3):400–404. https://doi.org/10.18295/squmj.5.2022.040
26. Akçay N., Menentoğlu M.E., Bektaş G., Şevketoğlu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol. 2021;93(9):5599–5602. https://doi.org/10.1002/jmv.27018
27. Pourbakhtyaran E., Heidari M., Akbari M.G., Mohammadi M., Badv R.S., Zamani G., Tavasoli A.R., Rezaei Z., Mamishi S., Haji Esmaeil Memar E., Hosseiny S.M.M., Ghabeli H., Haghighi R., Ashrafi M.R. Childhood Guillain-Barre syndrome in the SARS-CoV-2 era: Is there any causative relation? Clin Case Rep. 2022;10(12):e6772. https://doi.org/10.1002/ccr3.6772
28. Levison L.S., Thomsen R.W., Markvardsen L.K., Christensen D.H., Sindrup S.H., Andersen H. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020;107:57–63. https://doi.org/10.1016/j.pediatrneurol.2020.01.017
29. Kobayashi Takahashi Y., Hayakawa I., Abe Y. Diagnostic odyssey of Guillain-Barré syndrome in children. Brain Dev. 2024;46(2):108–113. https://doi.org/10.1016/j.braindev.2023.10.004
30. Tiwari I., Alam A., Kanta C., Koonwar S., Garg R.K., Pandey S., Jain A., Kumar R. Clinical Profile and Predictors of Mechanical Ventilation in Guillain-Barre Syndrome in North Indian Children. J Child Neurol. 2021;36(6):453–460. https://doi.org/10.1177/0883073820978020
31. Brisset M., Nicolas G. Peripheral neuropathies and aging. Geriatr Psychol Neuropsychiatr Vieil. 2018;16(4):409–413. https://doi.org/10.1684/pnv.2018.0768
32. Peric S., Berisavac I., Stojiljkovic Tamas O., Rajic S., Babic M., Cvijanovic M., Dominovic-Kovacevic A., Basta I., Beslac-Bumbasirevic L., Lavrnic D. Guillain-Barré syndrome in the elderly. J Peripher Nerv Syst. 2016;21(2):105–110. https://doi.org/10.1111/jns.12163
33. Briseño-Godínez M.E., Arauz A., López-Hernández J.C., de Saráchaga A.J., Pérez-Valdez E.Y., May-Más R.N., López-Hernández G., Bazán-Rodriguez L., Galnares-Olalde J.A., León-Manríquez E., Vargas-Cañas E.S. Prognostic Factors in Elderly Patients With Guillain-Barré Syndrome: Does Age Matter? Neurohospitalist. 2021;11(4):303–309. https://doi.org/10.1177/19418744211002676
34. Minamino M., Miyamoto K., Kuwahara M., Yoshikawa K., Koh J., Kusunoki S., Nagai Y., Ito H. Characteristics of Guillain-Barré syndrome in super-elderly individuals. J Neurol. 2023; 270(4):2191–2196. https://doi.org/10.1007/s00415-023-11567-8
35. Kim S., Han H.J., Shin H.Y., Kim S.W. Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome. Sci Rep. 2022;12(1):9913. https://doi.org/10.1038/s41598-022-14184-z
36. Bose S., Loo L.K., Rajabally Y.A. Causes and consequences of diagnostic delay in Guillain-Barré syndrome in a UK tertiary center. Muscle Nerve. 2022;65(5):547–552. https://doi.org/10.1002/mus.27506
37. Lee H.S., Suh B.C., Kim J.K., Kim B.J., Nam T.S., Oh J., Bae J.S., Shin K.J., Kim S.W., Kim S.M., Shin H.Y. Serial Nerve Conduction Studies in Guillain-Barré Syndrome: Its Usefulness and Precise Timing. J Clin Neurophysiol. 2024;41(3):278–284. https://doi.org/10.1097/WNP.0000000000000985
38. Rath J., Schober B., Zulehner G., Grisold A., Krenn M., Cetin H., Zimprich F. Nerve conduction studies in Guillain-Barré syndrome: Influence of timing and value of repeated measurements. J Neurol Sci. 2021;420:117267. https://doi.org/10.1016/j.jns.2020.117267
39. He S., Lin Y. Application and Value of Limbs Peripheral Nerve Ultrasound in Guillain-Barre Syndrome. Altern Ther Health Med. 2024;30(10):416–421. https://alternative-therapies.com/oa/index.html?fid=9248. (доступ не ограничен)
40. Umapathi T., Lim C.S.J., Ng B.C.J., Goh E.J.H., Ohnmar O. A Simplified, Graded, Electrodiagnostic Criterion for Guillain-Barré Syndrome That Incorporates Sensory Nerve Conduction Studies. Sci Rep. 2019;9(1):7724. https://doi.org/10.1038/s41598-019-44090-w
41. Uncini A., Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018;129(12):2586–2593. https://doi.org/10.1016/j.clinph.2018.09.025
42. López-Hernández J.C., Galnares-Olalde J.A., Jorge de Saráchaga A., Briseño-Godínez M.E., Pérez-Valdez E., May-Mas R.N., Arista-Ramírez J.L., Bazán-Rodríguez L., León-Manriquez E., Burgos-Centeno J., Vargas-Cañas E.S. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci. 2022;43(6):3923–3928. https://doi.org/10.1007/s10072-021-05834-7
43. Sung E.J., Kim D.Y., Chang M.C., Ko E.J. Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome. Ann Rehabil Med. 2016;40(3):481–488. https://doi.org/10.5535/arm.2016.40.3.481
44. Naresh K., Roy A., Srivastava S., Premkumar P., Nair A., Mani A.M., Shaikh A., Thirumal P.A., Sivadasan A., Mathew V., Premkumar P.S., Benjamin R. Sensitivity and specificity of phrenic nerve electrophysiology to predict mechanical ventilation in the Guillain-Barré syndrome. Muscle Nerve. 2023;68(2):191–197. https://doi.org/10.1002/mus.27918
45. Pasutharnchat N., Ratanasirisawad V., Santananukarn M., Taychargumpoo C., Amornvit J., Chunharas C. Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain-Barre syndrome. Clin Neurophysiol Pract. 2022;7:266–272. https://doi.org/10.1016/j.cnp.2022.09.001
46. Liu L., Ye Y., Wang L., Song X., Cao J., Qi Y., Xing Y. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China. Muscle Nerve. 2021;64(5):560–566. https://doi.org/10.1002/mus.27386
47. Mori A., Nodera H., Takamatsu N., Maruyama-Saladini K., Osaki Y., Shimatani Y., Kaji R. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome. J Neurol Sci. 2016;364:154–159. https://doi.org/10.1016/j.jns.2016.03.042
48. Piradov M.A., Suponeva N.A., Grishina D.A., Gnedovskaya E.V. Quality of life and social adaptation of patients with Guillain-Barré syndrome. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2013;113(8):61-67 (Russian). https://www.mediasphera.ru/myfirst_app/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2013/8/031997-72982013811 (доступ не ограничен).
49. Shang P., Feng J., Wu W., Zhang H.L. Intensive Care and Treatment of Severe Guillain-Barré Syndrome. Front Pharmacol. 2021;12:608130. https://doi.org/10.3389/fphar.2021.608130
50. Zaki H.A., Iftikhar H., Najam M., Masood M., Al-Marri N.D.R., Elgassim M., Fayed M., Shaban E.E. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis. eNeurologicalSci. 2023;31:100468. https://doi.org/10.1016/j.ensci.2023.100468
51. Nandeesha S.S., Kasagga A., Hawrami C., Ricci E., Hailu K.T., Salib K., Butt S. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review. Cureus. 2024;16(3):e57066. https://doi.org/10.7759/cureus.57066
52. Haridy N.A., Shehab M.M., Khedr E.M. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial. Restor Neurol Neurosci. 2023;41(5-6):203–217. https://doi.org/10.3233/RNN-231369
53. Bondi M., Engel-Haber E., Wolff J., Grosman-Rimon L., Bloch A., Zeilig G. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange. Neurorehabilitation. 2021;48(4):543–551. https://doi.org/10.3233/NRE-201640
54. Hughes R.A.C. Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions. Eur J Neurol. 2024;31(11):e16346. https://doi.org/10.1111/ene.16346
55. Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288
56. Busl K.M., Fried H., Muehlschlegel S., Wartenberg K.E., Rajajee V., Alexander S.A., Creutzfeldt C.J., Fontaine G.V., Hocker S.E., Hwang D.Y., Kim K.S., Madzar D., Mahanes D., Mainali S., Meixensberger J., Sakowitz O.W., Varelas P.N., Westermaier T., Weimar C. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome. Neurocrit Care. 2023;38:564–583. https://doi.org/10.1007/s12028-023-01707-3
57. Bazaraa H.M., Rady H.I., Mohamed S.A., Rabie W.A., ElAnwar N.H. Initial Response and Outcome of Critically Ill Children With Guillain Barre’ Syndrome. Front Pediatr. 2019;7:378. https://doi.org/10.3389/fped.2019.00378
58. Bhagwat A.P., Sharath H.V., Warghat P.A. Effect of Paediatric Rehabilitation in Children With Guillain-Barré Syndrome: A Case Series. Cureus. 2024;16(5):e59815. https://doi.org/10.7759/cureus.59815
59. Ponomarenko GN. Physical therapy: the prospects for its systemic development. Problems of Balneology, Physiotherapy and Exercise Therapy (Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul’tury). 2017;94(6):59-64 (Russian). https://doi.org/10.17116/kurort201794659-64
60. Arya N.P., Seth N.H., Raghuveer R., Sewani Y. Exploring the Efficacy of Physiotherapy in Guillain-Barré Syndrome Through Virtual Reality-Based Rehabilitation: A Case Report. Cureus. 2024;16(4):e59042. https://doi.org/10.7759/cureus.59042
61. Agnihotri S., Srivastava A., Gupta D., Naeem F. Rehabilitation of a Chronic Guillain-Barré Syndrome Patient With Vibratory Motor Stimulation of Dorsiflexors: A Case Report. Cureus. 2024;16(2):e53936. https://doi.org/10.7759/cureus.53936
62. Gawande I., Akhuj A., Samal S.. Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report. Cureus. 2024;16(1):e52062. https://doi.org/10.7759/cureus.52062
63. Kariya G., Salphale V.G., Dadgal R. Effectiveness of Symptomatic Physiotherapy in Enhancing the Psychological Parameters of a Patient With Guillain-Barré Syndrome: A Case Report. Cureus. 2024;16(3):e55389. https://doi.org/10.7759/cureus.55389
64. Uz F.B., Uz C., Karaahmet O.Z. Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation. Malawi Med J. 2023;35(3):156–162. https://doi.org/10.4314/mmj.v35i3.4
65. Kas’janenko K.V., Kozlov K.V., Zhdanov K.V., Lapikov I.I., Belikov V.V. SARS-CoV-2 severity prediction in young adults using artificial intelligence. Journal Infectology (Zhurnal infektologii). 2022;14(5):14–25 (Russian). https://doi.org/10.22625/2072-6732-2022-14-5-14-25
66. Suponeva N.A., Mochalova E.G., Grishina D.A., Piradov M.A. The specific features of Guillain–Barré syndrome in Russia: Analysis of 186 cases. Neuromuscular Diseases (Nervno-myshechnye bolezni). 2014;(1):37–46 (Russian). https://doi.org/10.17650/2222-8721-2014-0-1-40-47
67. Kozyreva AA, Bembeeva RTs, Druzhinina ES, Zavadenko NN. Guillain—Barre syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2023;123(9-2):20-32 (Russian). https://doi.org/10.17116/jnevro202312309220
Review
For citations:
Voitenkov V.B., Samojlova I.G., Skripchenko E.Yu., Cherkashina I.V., Klimkin A.V., Irikova M.A., Verbenko P.S. Acute motor axonal neuropathy: features of diagnosis, treatment and rehabilitation. Russian neurological journal. 2024;29(6):20-26. (In Russ.) https://doi.org/10.30629/2658-7947-2024-29-6-20-26
Views:
329
Email this article 